These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18563637)

  • 21. Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations.
    García-Morales EJ; Cariappa R; Parvin CA; Scott MG; Diringer MN
    Crit Care Med; 2004 Apr; 32(4):986-91. PubMed ID: 15071390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for Mannitol as an Effective Agent Against Intracranial Hypertension: An Individual Patient Data Meta-analysis.
    Poole D; Citerio G; Helbok R; Ichai C; Meyfroidt G; Oddo M; Payen JF; Stocchetti N
    Neurocrit Care; 2020 Feb; 32(1):252-261. PubMed ID: 31264071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linear correlation between stable intracranial pressure decrease and regional cerebral oxygenation improvement following mannitol administration in severe acute head injury patients.
    Gasco J; Sendra J; Lim J; Ng I
    Acta Neurochir Suppl; 2005; 95():73-7. PubMed ID: 16463824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenging the gold standard: should mannitol remain our first-line defense against intracranial hypertension?
    Infanti JL
    J Neurosci Nurs; 2008 Dec; 40(6):362-8. PubMed ID: 19170304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The internal environment and intracranial hypertension].
    Ichai C; Ciais JF; Grimaud D
    Ann Fr Anesth Reanim; 1997; 16(4):435-44. PubMed ID: 9750595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osmotic therapy: fact and fiction.
    Diringer MN; Zazulia AR
    Neurocrit Care; 2004; 1(2):219-33. PubMed ID: 16174920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperosmolar therapy in the treatment of severe head injury in children: mannitol and hypertonic saline.
    Knapp JM
    AACN Clin Issues; 2005; 16(2):199-211. PubMed ID: 15876888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mannitol and hypertonic saline: going head to head.
    Härtl R; Froelich M
    Crit Care Med; 2008 Mar; 36(3):1005-6. PubMed ID: 18431303
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypertonic saline ameliorates cerebral edema associated with experimental brain tumor.
    Toung TJ; Tyler B; Brem H; Traystman RJ; Hurn PD; Bhardwaj A
    J Neurosurg Anesthesiol; 2002 Jul; 14(3):187-93. PubMed ID: 12172290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy and safety of glycerol versus mannitol in patients with cerebral oedema and elevated intracranial pressure: A systematic review and meta-analysis.
    Wang J; Ren Y; Wang SF; Kan LD; Zhou LJ; Fang HM; Fan H
    J Clin Pharm Ther; 2021 Apr; 46(2):504-514. PubMed ID: 33217016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertonic saline solutions for treatment of intracranial hypertension.
    Himmelseher S
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):414-26. PubMed ID: 17873594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol.
    Vialet R; Albanèse J; Thomachot L; Antonini F; Bourgouin A; Alliez B; Martin C
    Crit Care Med; 2003 Jun; 31(6):1683-7. PubMed ID: 12794404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury.
    Battison C; Andrews PJ; Graham C; Petty T
    Crit Care Med; 2005 Jan; 33(1):196-202; discussion 257-8. PubMed ID: 15644669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial [ISRCTN62699180].
    Harutjunyan L; Holz C; Rieger A; Menzel M; Grond S; Soukup J
    Crit Care; 2005 Oct; 9(5):R530-40. PubMed ID: 16277715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertonic saline or mannitol for treating elevated intracranial pressure in traumatic brain injury: a meta-analysis of randomized controlled trials.
    Gu J; Huang H; Huang Y; Sun H; Xu H
    Neurosurg Rev; 2019 Jun; 42(2):499-509. PubMed ID: 29905883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of mannitol on cerebral blood volume in patients with head injury.
    Diringer MN; Scalfani MT; Zazulia AR; Videen TO; Dhar R; Powers WJ
    Neurosurgery; 2012 May; 70(5):1215-8; discussion 1219. PubMed ID: 22089753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Osmotic Therapy on Pupil Reactivity: Quantification Using Pupillometry in Critically Ill Neurologic Patients.
    Ong C; Hutch M; Barra M; Kim A; Zafar S; Smirnakis S
    Neurocrit Care; 2019 Apr; 30(2):307-315. PubMed ID: 30298336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of equiosmolar dose of hyperosmolar agents in reducing intracranial pressure-a randomized control study in pediatric traumatic brain injury.
    Kumar SA; Devi BI; Reddy M; Shukla D
    Childs Nerv Syst; 2019 Jun; 35(6):999-1005. PubMed ID: 30879126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Evolution of the Clinical Use of Osmotic Therapy in the Treatment of Cerebral Edema.
    Diringer MN
    Acta Neurochir Suppl; 2016; 121():3-6. PubMed ID: 26463914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of equiosmolar load of 20% mannitol, 7.5% saline and 0.9% saline on plasma osmolarity, haemodynamics and plasma concentrations of electrolytes].
    Erard AC; Walder B; Ravussin P
    Ann Fr Anesth Reanim; 2003 Jan; 22(1):18-24. PubMed ID: 12738015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.